While the molecular mechanisms underlying this effect are currently not completely understood, our data suggest that in the face of renal ACE deficiency, AAI may activate the ACE2/Ang(1–7)/Mas pathway, which in turn may deploy its well-known reno-protective effects. The gene discussed is ACE; the disease is hyperinsulinemic hypoglycemia, familial, 4.